Observed distributions of P-glycoprotein substrate verapamil to brain in control, pentylenetetrazole, phenytoin, and spontaneous model of epilepsy mice
Mice received constant intravenous infusion of verapamil to the jugular vein at a rate of 500 nmol/h per kg following 1-minute rapid infusion (500 nmol/min per kg). The plasma and brain concentrations were measured at 45 minutes, and the brain-to-plasma concentration ratio (Kp brain) values were calculated by dividing the brain concentration by the plasma concentration. Each value represents the mean ± S.E.M. (n = 3–4).
Plasma Concentration | Brain Concentration | Kp brain | |
---|---|---|---|
nM | pmol/g brain | ml/g brain | |
Control | 101 ± 9 | 56.7 ± 8.3 | 0.563 ± 0.074 |
PTZ | 93.4 ± 3.4 | 36.6 ± 2.2 | 0.394 ± 0.034 |
EL | 156 ± 7 | 66.3 ± 9.7 | 0.432 ± 0.084 |
PHT | 83.0 ± 6.7 | 19.2 ± 1.2 | 0.234 ± 0.016** |
↵** P < 0.01: significantly different from Kp brain value in control mice (Dunnett’s test).